Key result
A newly developed dual ELISA successfully differentiated wild-type ASFV from CD2v-unexpressed mutants with high specificity and sensitivity up to a 1:5120 dilution.
Why the study?
Existing OIE-recommended quantitative PCR and ELISA methods cannot distinguish between infection with CD2v-unexpressed lower-virulence mutants and wild-type African swine fever virus.
Does a dual ELISA based on CD2v and p30 proteins accurately differentiate wild-type ASFV from CD2v-unexpressed lower-virulence mutants?
Does a dual ELISA based on CD2v and p30 proteins accurately differentiate wild-type ASFV from CD2v-unexpressed lower-virulence mutants?
Answers are grounded in this paper and cite their sources.
A newly developed dual ELISA can successfully differentiate between wild-type African swine fever virus and CD2v-unexpressed lower-virulence mutants, filling a gap in veterinary diagnostic capabilities.
African swine fever virus (ASFV) is an important viral pathogen infecting pigs worldwide throughout the pig industry. CD2v (an outer-membrane glycosylated protein of ASFV)-unexpressed lower-virulence mutants have appeared in China and other countries in recent years. Using OIE-recommended quantitative PCR and ELISA methods, people can accurately judge whether pigs are infected with wild-type ASFV. However, the strategy has failed to distinguish ΔCD2v lower-virulence mutants and wild-type ASFV infection. Here, we expressed and purified the CD2v and p30 proteins via CHO cells and successfully established a dual enzyme-linked immunosorbent assay (ELISA), which can be used to differentiate pigs infected with wild-type ASFV or with CD2v-unexpressed lower-virulence mutants. The dual ELISA showed excellent specificity without cross-reactions with antibodies of PRRSV, CSFV, JEV, PRV, or PPV. The dual ELISA could detect ASFV-infected positive serum samples up to dilutions of 5120 times, possessing high sensitivity. Therefore, the application of this dual ELISA approach can play an important role in ASFV epidemiology study and fill the gaps in differential diagnosis.
No takes yet. Share an insight, caveat, or question.
Lv et al. (2021) studied African swine fever virus (ASFV) infection. Dual enzyme-linked immunosorbent assay (ELISA) using CD2v and p30 proteins was evaluated on Differentiation of wild-type ASFV and CD2v-unexpressed lower-virulence mutants. A newly developed dual ELISA successfully differentiated wild-type ASFV from CD2v-unexpressed mutants with high specificity and sensitivity up to a 1:5120 dilution.
Synapse has enriched 10 related papers. Consider them for comparative context: